The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance
Open accessAbstract
Data from basic research suggests that amplification of the proto-oncogene c-myc is important in breast cancer pathogenesis, but its frequency of amplification and prognostic relevance in human studies have been inconsistent. In an effort to clarify the clinical significance of c-myc amplification in breast cancer, we conducted a comprehensive literature search and a meta-analysis in which 29 studies were evaluated. The weighted average frequency of c-myc amplification in breast tumours was 15.7% (95% CI = 12.5-18.8%), although estimates in individual studies exhibited significant heterogeneity, P<0.0001. C-myc amplification exhibited significant but weak associations with tumour grade (RR = 1.61), lymph-node metastasis (RR = 1.24), negative progesterone receptor status (RR = 1.27), and postmenopausal status (RR = 0.82). Amplification was significantly associated with risk of relapse and death, with pooled estimates RR = 2.05 (95% CI = 1.51-2.78) and RR = 1.74 (95% CI = 1.27-2.39), respectively. This effect did not appear to be merely a surrogate for other prognostic factors. These results suggest that c-myc amplification is relatively common in breast cancer and may provide independent prognostic information. More rigorous studies with consistent methodology are required to validate this association, and to investigate its potential as a molecular predictor of specific therapy response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 8,990
Statistical Methods in Cancer Research
Breslow, N. E. (1980) · Cited by 7,332
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
Little, C. D., Nau, M. M., Carney, D. N., Gazdar, A. F., & Minna, J. D. (1983) · Nature · doi:10.1038/306194a0 · Cited by 920
Statistical methods in cancer research
Gardner, B. (2001) · Journal of Surgical Oncology · doi:10.1002/jso.1170 · Cited by 777
Alitalo, K., Schwab, M., Lin, C. C., Varmus, H. E., & Bishop, J. M. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1707 · Cited by 761
THE MOLECULAR GENETICS OF CELLULAR ONCOGENES
Varmus, H. E. (1984) · Annual Review of Genetics · doi:10.1146/annurev.ge.18.120184.003005 · Cited by 756
Apaf-1 and Caspase-9 in p53-Dependent Apoptosis and Tumor Inhibition
Soengas, M. S., Alarcón, R. M., Yoshida, H., J., A., Giaccia, Hakem, R., Mak, T. W., & Lowe, S. W. (1999) · Science · doi:10.1126/science.284.5411.156 · Cited by 660
Favera, R. D., Wong-Staal, F., & Gallo, R. C. (1982) · Nature · doi:10.1038/299061a0 · Cited by 628
Epidemiologic research—1964–1967
Greene, J. C. (1968) · The Journal of the American Dental Association · doi:10.14219/jada.archive.1968.0207 · Cited by 568
Meta-analysis: State-of-the-Science
Dickersin, K., & Berlin, J. A. (1992) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036084 · Cited by 498
Jenkins, R. B., Qian, J., Lieber, M. M., & Bostwick, D. G. (1997) · PubMed · Cited by 443
Trock, B. J., Leonessa, F., & Clarke, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.917 · Cited by 434
Self-citationChromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms.
Mertens, F., Johansson, B., Höglund, M., et al. (1997) · PubMed · Cited by 425
Leder, A., Pattengale, P. K., Kuo, A., Stewart, T. A., & Leder, P. (1986) · Cell · doi:10.1016/0092-8674(86)90280-1 · Cited by 423
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas.
Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champeme, M. H., Gest, J., & Callahan, R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4834 · Cited by 412
Varley, J. M., Swallow, J. E., Brammar, W. J., Whittaker, J. L., & Walker, R. A. (1987) · PubMed · Cited by 360
Tsuda, H., Hirohashi, S., Shimosato, Y., Hirota, T., Tsugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., Yamamoto, T. S., & Yokota, J. (1989) · PubMed · Cited by 317
Planning the size and duration of a clinical trial studying the time to some critical event
George, S. L., & Desu, M. M. (1974) · Journal of Chronic Diseases · doi:10.1016/0021-9681(74)90004-6 · Cited by 279
Courjal, F., Cuny, M., Simony-Lafontaine, J., Louason, G., Speiser, P., Zeillinger, R., Rodríguez, C., & Theillet, C. G. (1997) · PubMed · Cited by 238
Berns, E., Klijn, J. G. M., van Putten, W. L., van Staveren, I. L., Portengen, H., & Foekens, J. A. (1992) · PubMed · Cited by 201
Hayes, D. F., Trock, B., & Harris, A. L. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006197805041 · Cited by 184
Self-citationProto-oncogene amplification and human breast tumor phenotype
Adnane, J., Gaudray, P., Simon, M., Simony-Lafontaine, J., Jeanteur, P., & Theillet, C. G. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90028-5 · Cited by 151
Defining a role for c-Myc in breast tumorigenesis
Nass, S. J., & Dickson, R. B. (1997) · Breast Cancer Research and Treatment · doi:10.1023/a:1005858611585 · Cited by 130
Self-citationZhou, D. J., Ahuja, H., & Cline, M. J. (1989) · PubMed · Cited by 125
Berns, E. M. J. J., Klijn, J. G. M., van Staveren, I. L., Portengen, H., Noordegraaf, E., & Foekens, J. A. (1992) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80129-7 · Cited by 120
c‐myc amplification is an independent prognostic factor in postmenopausal breast cancer
Borg, Å., Baldetorp, B., Fernö, M., Olsson, H. L., & Sigurdsson, H. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510504 · Cited by 105
Watson, P. H., Safneck, J. R., Le, K., Dubik, D., & Shiu, R. P. C. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.11.902 · Cited by 85
Kreipe, H. H., Feist, H., Fischer, L., Felgner, J., Heidorn, K., Mettler, L., & Parwaresch, R. M. (1993) · PubMed · Cited by 73
Tavassoli, M., Quirke, P., Farzaneh, F., Lock, N., Mayne, L., & Kirkham, N. (1989) · British Journal of Cancer · doi:10.1038/bjc.1989.303 · Cited by 67
Roux-Rouquié, M., Romain, S., Dussault, N., Desideri, C., Piana, L., Bonnier, P., Tubiana-Mathieu, N., & Martin, P. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90050-c · Cited by 51
Cellular mechanisms associated with the lack of chronic thermotolerance expression in HeLa S3 cells.
Mackey, M. A., Anolik, S. L., & Roti, J. L. R. (1992) · PubMed · Cited by 51
Analysis of the int-1, int-2, c-myc, and neu oncogenes in human breast carcinomas.
Meyers, S., O'Brien, M. T., Smith, T., & Dudley, J. P. (1990) · PubMed · Cited by 47
Tumour cells surviving in vivo cisplatin chemotherapy display elevated c-myc expression
Walker, T., White, J. D., Esdale, W., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.105 · Cited by 44
Analysis of Oncogenes and Tumor Suppressor Genes in Human Breast Cancer
Yamashita, H., Kobayashi, S., Iwase, H., Itoh, Y., Kuzushima, T., Iwata, H., Itoh, K., Naito, A., Yamashita, T., Masaoka, A., et al. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02060.x · Cited by 37
Sierra, À., Castellsagué, X., Escobedo, A., Moreno, A., Drudis, T., & Fabra, À. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006120006471 · Cited by 29
Champème, M. H., Bièche, I., Hacène, K., & Lidereau, R. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110403 · Cited by 7
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer
Wang, Y., Zhang, T., Kwiatkowski, N., Abraham, B. J., Lee, T. I., Xie, S., Yuzugullu, H., Von, T., Li, H., Lin, Z., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.063 · Cited by 465
Zhan, L., Rosenberg, A., Bergami, K. C., Yu, M., Xuan, Z., Jaffe, A. B., Allred, C., & Muthuswamy, S. K. (2008) · Cell · doi:10.1016/j.cell.2008.09.045 · Cited by 436
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
Kessler, J. D., Kahle, K. T., Sun, T., Meerbrey, K. L., Schlabach, M. R., Schmitt, E. M., Skinner, S. O., Xu, Q., Li, M. Z., Hartman, Z. C., et al. (2012) · Science · doi:10.1126/science.1212728 · Cited by 433
Metadata
- Authors
- Deming, S. L., Nass, S. J., Dickson, R. B., & Trock, B. J.
- Venue
- British Journal of Cancer
- Published
- 2000-12
- Volume
- 83
- Issue
- 12
- Pages
- 1688-1695
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W1978158433
- Cited by
- 302
- References
- 38
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.